Explore Business Standard
Biocon Biologics, a subsidiary of Biocon, on Monday said its biosimilar to treat certain inflammatory diseases is now available in the US market. The company said HULIO (adalimumab) injection, a biosimilar to Humira (adalimumab), is now available to patients in the US after five years of experience in Europe and two years in Canada. "The launch of HULIO, our biosimilar adalimumab, in the US, is an important milestone for Biocon Biologics as it expands our well-known biosimilar product offering to patients in the US," Biocon Biologics CEO and MD Shreehas Tambe said in a statement. This launch builds on the company's strong presence in oncology and diabetes, he added.
A simple cup of coffee with milk may have an anti-inflammatory effect in humans, a study conducted in laboratory suggests. Researchers from the University of Copenhagen in Denmark found that a combination of proteins and antioxidants doubles the anti-inflammatory properties in immune cells. Whenever bacteria, viruses and other foreign substances enter the body, our immune systems react by deploying white blood cells and chemical substances to protect us. This reaction, commonly known as inflammation, also occurs whenever we overload tendons and muscles and is characteristic of diseases like rheumatoid arthritis. Antioxidants known as polyphenols are found in humans, plants, fruits and vegetables. They are also known to be healthy for humans, as they help reduce oxidative stress in the body that gives rise to inflammation. The study, published in the Journal of Agricultural and Food Chemistry, analysed how polyphenols behave when combined with amino acids, the building blocks of ..